Keyphrases
5-HT2C Receptor
100%
Discriminative Stimulus
100%
Stimulus Properties
100%
MCPP
100%
Receptor Antagonist
33%
5-hydroxytryptamine
33%
Receptor Agonist
33%
5-HT1A
22%
Fenfluramine
22%
Reuptake
11%
5-HT Receptors
11%
Drug Discrimination
11%
Discriminative Stimulus Effects
11%
Discrimination Task
11%
Spontaneous Excitatory Postsynaptic Current (sEPSC)
11%
5-HT Receptor Agonists
11%
5-HT1B
11%
Antidepressants
11%
Haloperidol
11%
Consecutive Days
11%
Reinforced
11%
2 Receptor
11%
Ketanserin
11%
Trazodone
11%
5-HT3 Receptor
11%
Lysergic Acid Diethylamide
11%
SCH23390
11%
Piperazine
11%
Para-chlorophenylalanine
11%
Dopamine Receptor Antagonist
11%
Partial Agonist
11%
5-HT Synthesis
11%
Co-agonist
11%
Releaser
11%
Metergoline
11%
RU 24969
11%
Cabergoline
11%
Neuroscience
5-HT2C Receptor
100%
Meta-Chlorophenylpiperazine
100%
Receptor Agonists
44%
Receptor Antagonist
22%
Agonist
22%
2,5-Dimethoxy-4-iodoamphetamine
22%
Fenfluramine
22%
Reuptake
11%
5-HT Receptor
11%
Drug Discrimination
11%
Serotonin Antagonist
11%
Antidepressant
11%
Trazodone
11%
Serotonin 3 Receptor
11%
Lysergic Acid Diethylamide
11%
Dopamine Antagonist
11%
SCH 23390
11%
Fenclonine
11%
Trifluoromethylphenylpiperazine
11%
Ergoline
11%
Mesulergine
11%
Haloperidol
11%
Ketanserin
11%
Metergoline
11%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Meta-Chlorophenylpiperazine
100%
Receptor Agonist
33%
Receptor Antagonist
22%
Fenfluramine
22%
2,5-Dimethoxy-4-iodoamphetamine
22%
Serotonin Agonist
11%
Serotonin Antagonist
11%
Antidepressant
11%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
11%
Ketanserin
11%
Serotonin 3 Receptor
11%
Lysergide
11%
Dopamine Receptor Blocking Agent
11%
Trazodone
11%
Fenclonine
11%
Trifluoromethylphenylpiperazine
11%
Partial Agonist
11%
Agonist-Antagonist
11%
Metergoline
11%
Mesulergine
11%
Ergoline Derivative
11%
Table Salt
11%
Ergoline
11%